Psychemedics Corp
PMDDelisted Dec 13, 2024- Industry
- Services-Medical Laboratories
- SEC CIK
- 0000806517
Psychemedics Corp was delisted on Dec 13, 2024; its insiders filed their last Form 4 on Dec 17, 2024; 21 institutions reported holding it in 13F filings for Q3 2024, worth $2.85M in total; no superinvestor held it.
13F holders, Q4 2023
Institutional positions in Psychemedics Corp as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- −2 vs. Q3 2023
- Shares held
- 1.29M
- −141.5K (−9.9%) vs. Q3 2023
- Total value
- $3.82M
- −$1.86M (−32.8%) vs. Q3 2023
- New holders
- 1
- 6 more added
- Sold out
- 3
- 10 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 1 | $441.7K |
| Q3 2025 | 1 | $582.4K |
| Q2 2025 | 1 | $618.3K |
| Q1 2025 | 1 | $643.2K |
| Q4 2024 | 3 | $708.7K |
| Q3 2024 | 21 | $2.85M |
| Q2 2024 | 26 | $2.87M |
| Q1 2024 | 22 | $3.54M |
| Q4 2023 | 23 | $3.82M |
| Q3 2023 | 25 | $5.68M |
| Q2 2023 | 21 | $6.32M |
| Q1 2023 | 20 | $7.34M |
| Q4 2022 | 22 | $6.93M |
| Q3 2022 | 23 | $9.54M |
| Q2 2022 | 21 | $9.55M |
| Q1 2022 | 25 | $11.0M |
| Q4 2021 | 25 | $11.4M |
| Q3 2021 | 28 | $13.9M |
| Q2 2021 | 28 | $12.4M |
| Q1 2021 | 31 | $11.5M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Psychemedics Corp; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| 22NW, LP | 274,418 | $812.3K | 0.53% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 265,563 | $786.0K | 0.00% | −8,100−3.0% | Reduced |
| Vanguard Group Inc | 251,283 | $743.8K | 0.00% | +132+0.1% | Added |
| RBF Capital, LLC | 142,142 | $420.7K | 0.03% | −2,089−1.4% | Reduced |
| Ancora Advisors, LLC | 78,173 | $231.4K | 0.01% | −200−0.3% | Reduced |
| BlackRock Inc. | 77,267 | $228.7K | 0.00% | −114−0.1% | Reduced |
| Wedbush Securities Inc | 48,664 | $144.0K | 0.01% | +6,250+14.7% | Added |
| Geode Capital Management, LLC | 36,596 | $108.4K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 36,117 | $106.9K | 0.00% | −2,067−5.4% | Reduced |
| Crawford Investment Counsel Inc | 20,098 | $59.5K | 0.00% | −12,000−37.4% | Reduced |
| Santa Monica Partners LP | 20,000 | $59.0K | 0.04% | 00.0% | Unchanged |
| Citadel Advisors LLC | 16,200 | $48.0K | 0.00% | −4,238−20.7% | Reduced |
| Northern Trust Corp | 15,310 | $45.3K | 0.00% | −1,554−9.2% | Reduced |
| Morgan Stanley | 3,501 | $10.4K | 0.00% | −999−22.2% | Reduced |
| Tower Research Capital LLC (TRC) | 2,321 | $6.87K | 0.00% | +584+33.6% | Added |
| Your Advocates Ltd., LLP | 1,400 | $4.14K | 0.00% | 00.0% | Unchanged |
| Provenance Wealth Advisors, LLC | 772 | $2.29K | 0.00% | 00.0% | Unchanged |
| FMR LLC | 625 | $1.85K | 0.00% | +525+525.0% | Added |
| Wells Fargo & Company | 37 | $110 | 0.00% | +2+5.7% | Added |
| Caldwell Sutter Capital, Inc. | 30 | $89 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 8 | $24 | 0.00% | +3+60.0% | Added |
| Bank of America Corp | 3 | $9 | 0.00% | +3 | New |
| Royal Bank of Canada | 28 | $0 | 0.00% | −2,106−98.7% | Reduced |
| Cannell Capital LLC | 0 | $0 | 0.00% | −74,794−100.0% | Sold out |
| Wealth Effects LLC | 0 | $0 | 0.00% | −40,701−100.0% | Sold out |
| Capital Advisors, Ltd. LLC | 0 | $0 | 0.00% | −60−100.0% | Sold out |